Tracheoesophageal fistula developing during chemotherapy for non-Hodgkins lymphoma

J Surg Oncol. 1996 Dec;63(4):265-7. doi: 10.1002/(SICI)1096-9098(199612)63:4<265::AID-JSO9>3.0.CO;2-A.

Abstract

Lymphoma is an unusual cause of tracheoesophageal fistula (TEF). Most fistulas develop after radiation therapy and are a rare occurrence in patients treated with chemotherapy alone. The presence of a TEF is usually indicative of active lymphoma. This report describes a tracheoesophageal fistula that developed during chemotherapy for diffuse large cell lymphoma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / complications*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Male
  • Mitoxantrone / administration & dosage
  • Prednisone / administration & dosage
  • Tomography, X-Ray Computed
  • Tracheoesophageal Fistula / diagnostic imaging
  • Tracheoesophageal Fistula / etiology*
  • Tracheoesophageal Fistula / surgery
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Cyclophosphamide
  • Mitoxantrone
  • Prednisone